PPD GenuPro

PPD, now a part of Thermo Fisher Scientific, is a leading global contract research organization (CRO) providing comprehensive drug development, laboratory, and lifecycle management services. The company's GenuPro platform is a proprietary, standardized process specifically engineered for late-stage research, including Phase IIIb and Phase IV clinical trials, as well as real-world evidence (RWE) studies. GenuPro enables pharmaceutical and biotech companies to efficiently generate the evidence required for product optimization, regulatory requirements, and market access. By integrating advanced data analytics with global operational scale, PPD supports the entire drug development continuum from early-phase trials to post-approval monitoring. The platform focuses on streamlining study startup, ensuring high-quality data collection, and accelerating the delivery of results for global regulatory submissions.